Image

Global In-Vivo Imaging Market – Industry Trends and Forecast to 2028

  • Healthcare
  • Upcoming Report
  • Jun 2021
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global In-Vivo Imaging Market, By Modality (Optical Imaging Systems, Nuclear Imaging Systems, Micro-MRI, Micro-Ultrasound, Micro-CT, Photoacoustic Imaging Systems, Magnetic Particle Imaging Systems), Reagents (Optical Imaging Reagents, Nuclear Imaging Reagents, MRI Contrast Agents, Ultrasound Contrast Agents, CT Contrast Agents), Techniques (Radioisotopes Based, Biomarkers Based, Luminescent Proteins Based, Others), End User (Hospitals and Clinics, Imaging Centers, Research Organizations, Others),Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028

In-Vivo Imaging Market

Market Analysis and Insights of In-Vivo Imaging : Global In-Vivo Imaging Market

The in-vivo imaging market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to USD 1,333.81 million by 2028 and will grow at a CAGR of 5.78% in the above mentioned forecast period.

The in vivo imaging generally refers to the visualization of various life processes within an organism. In vivo imaging system helps in mechanizing in vivo imaging research with one-touch, user-defined or pre-set PC controls for repeatable and precise imaging.

The rapid technological advancement in the field of molecular imaging is amongst the important factor expected to intensify the growth and demand of in-vivo imaging market. In addition, the increase in the number of public-private initiatives and high funding to support preclinical researches are also expected contribute to the growth in the global market over the forecast period of 2021 to 2028. Also the rapid rise in the demand for noninvasive small-animal imaging techniques and rapid advancements in the healthcare services and technology are also likely to enhance the growth of the market. Furthermore, the increase in awareness regarding the benefits of early disease diagnosis and rise in the rate of acceptance of multi-modality imaging systems in clinical are also one of the significant factors expected to fuel the growth of thein-vivo imaging market.                                                        

The rise in healthcare expenditures and increase in the prevalence of cancer followed by R&D in the imaging technology for the diagnosis of various types of diseases such as cancer are anticipated to offer significant growth opportunities for the market in the forecast period of 2021 to 2028.

However, the high cost of clinical and preclinical imaging systems and low healthcare expenditures in developing countries are expected to curb the growth of the in-vivo imaging market, whereas the technological and procedural limitations coupled with standalone preclinical imaging systems can challenge the growth of the in-vivo imaging market.

This in-vivo imaging market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the in-vivo imaging market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global In-Vivo Imaging Market Scope and Market Size

The in-vivo imaging market is segmented on the basis of modality, reagents, techniques and end user. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

  • On the basis of modality, the in-vivo imaging market is segmented into optical imaging systems, nuclear imaging systems, micro-mri, micro-ultrasound, micro-CT, photoacoustic imaging systems and magnetic particle imaging systems. Optical imaging systems have further been segmented into bioluminescence/fluorescence imaging systems, standalone fluorescence imaging systems and optical + X-ray/optical + CT. Nuclear imaging systems have further been segmented into micro-PET systems, micro-SPECT systems and trimodality (SPECT/PET/CT) systems.
  • Based on reagents, the in-vivo imaging market is segmented into optical imaging reagents, nuclear imaging reagents, MRI contrast agents, ultrasound contrast agents and CT contrast agents. Optical imaging reagents have further been segmented into bioluminescent imaging reagents and fluorescent imaging reagents. Nuclear imaging reagents have further been segmented into PET tracers and SPECT probes. MRI contrast agents have further been segmented into gadolinium-based, iron-based and manganese-based. CT contrast agents have further been segmented into iodine-based, barium-based, gold nanoparticles and gastrografin-based.
  • On the basis of techniques, the in-vivo imaging market is segmented into radioisotopes based, biomarkers based, luminescent proteins based and others.
  • The end user segment of in-vivo imaging market is segmented into hospitals and clinics, imaging centers, research organizations and others.

In-Vivo Imaging Market Country Level Analysis

The in-vivo imaging market is analyzed and market size insights and trends are provided by country, modality, reagents, techniques and end user as referenced above.

The countries covered in the In-vivo imaging market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa(MEA), Brazil, Argentina and Rest of South America as part of South America.

North America region leads the In-vivo imaging market owing to the rise in prevalence of cancer and the strong presence of developed countries such as the U.S. and Canada. Asia-Pacific is expected to expand at a significant growth rate over the forecast period of 2021 to 2028 because of the high adoption of new technologies in the medical service sector in the developing economies such as India and China.                                                                                              

The country section of the in-vivo imaging market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

The in-vivo imaging market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for in-vivo imaging market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the in-vivo imaging market. The data is available for historic period 2010 to 2019.

Competitive Landscape and In-Vivo Imaging Market Share Analysis

The in-vivo imaging market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to in-vivo imaging market.

The major players covered in the in-vivo imaging marketreport are PerkinElmer Inc., Bruker, FUJIFILM Visualsonics, Inc., Siemens, Miltenyi Biotec, CMR Naviscan, SCANCO Medical AG, Aspect Imaging Ltd., Mediso USA, LI-COR, Inc., Takara Bio Inc., MILabs B.V., MR Solutions, Trifoil Imaging,New England Biolabs,Biospace Lab, Koninklijke Philips N.V, General Electric, Hitachi, Ltd., and Guerbet, among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Customization Available : Global In-Vivo Imaging Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions



Frequently Asked Questions

In-Vivo Imaging Market grow at a rate of CAGR 5.78% & value of USD 1,333.81 million
This in-vivo imaging market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market.
The major players covered in the in-vivo imaging marketreport are PerkinElmer Inc., Bruker, FUJIFILM Visualsonics, Inc., Siemens, Miltenyi Biotec, CMR Naviscan, SCANCO Medical AG, Aspect Imaging Ltd., Mediso USA, LI-COR, Inc., Takara Bio Inc., MILabs B.V., MR Solutions, Trifoil Imaging,New England Biolabs,Biospace Lab, Koninklijke Philips N.V, General Electric, Hitachi, Ltd., and Guerbet, among other domestic and global players
Asia-Pacific is expected to expand at a significant growth rate over the forecast period of 2021 to 2028 because of the high adoption of new technologies in the medical service sector in the developing economies such as India and China.